Why the study?
Does high blood pressure variability predict fatal and nonfatal cardiovascular events in treated hypertensive patients?
Does high blood pressure variability predict fatal and nonfatal cardiovascular events in treated hypertensive patients?
In treated hypertensive patients, blood pressure variability assessed by noninvasive monitoring is not an independent predictor of cardiovascular outcomes after adjusting for other established risk factors.
Answers are grounded in this paper and cite their sources.
High BP variability is not an independent predictor of CV events in treated hypertension; leaves open its added value beyond standard risk factors.
BACKGROUND: The independent prognostic value of blood pressure (BP) variability in treated hypertension is not yet clear. We investigated the relationship between BP variability, evaluated by noninvasive monitoring, and cardiovascular outcome in treated hypertensive patients. METHODS: The occurrence of fatal and nonfatal cardiovascular events was evaluated in 1472 treated patients. Subjects with the standard deviation of daytime or night-time systolic BP below or above the median of the population were classified as having low or high BP variability. Specifically, 738 and 734 patients had low and high daytime BP variability, respectively, and 739 and 733 subjects had low and high night-time BP variability, respectively. RESULTS: During follow-up (4.88 +/- 2.9 years, range 0.2-11.6 years) there were 119 events. The event rates per 100 patient-years in subjects with low and high BP variability according to daytime BP were 1.18 and 2.01, respectively, and in those with low and high BP variability according to night-time BP were 1.2 and 2.05, respectively. Event-free survival was significantly different between the low and high BP variability groups (P = .006 for both daytime and night-time BP). However, after adjustment for other covariates in a Cox multivariate analysis, the adverse prognostic relevance of high BP variability was no longer detectable, whereas age, smoking habit, LDL cholesterol, diabetes, previous events, LV hypertrophy, and daytime or night-time systolic BP resulted independent predictors of risk. CONCLUSIONS: Increased BP variability is associated with higher incidence of cardiovascular events, but also with other relevant prognostic factors. Indeed, in multivariate analysis the possible adverse prognostic impact of BP variability is no longer evident. Thus, in treated hypertension, BP variability evaluated by noninvasive monitoring is not an independent predictor of outcome.
No takes yet. Share an insight, caveat, or question.
Pierdomenico et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: